7 January 2020 Melbourne, Australia – Opthea Limited (ASX:OPT), a clinical stage biopharmaceutical company developing novel biologic therapies to treat eye diseases, has completed patient recruitment into the Company’s Phase 2a trial evaluating the safety and efficacy of…
18 December 2019 A media release from Senator the Hon. Anne Ruston MP, Acting Minister for Health, about $8.9 million for cancer research in Australia, through Cancer Australia’s Priority-driven Collaborative Cancer Research Scheme. … The Morrison Government has…
12 December 2019 The developers of a simple eye test to detect signs of Alzheimer’s disease have won funding to help take their technology from the lab to the eye clinic. Enlighten Imaging, an Australian start-up company incubated…
27 November 2019 By Watermark We are pleased to announce that our firm will be integrating into Australian IP firm Griffith Hack in April 2020, and from that time we will operate as one combined firm under the…
5 December 2019 By David Yeates, CSIRO, Katja Hogendoorn, University of Adelaide, Manu Saunders, University of New England 5 minute read Are you planning a big garden clean-up this summer, or stocking up on fly spray to keep bugs…
16 December 2019 The recent tragedy of White Island in New Zealand is a challenging situation for all involved. The surgical and trauma teams in many hospitals across New Zealand and Australia have put in heroic efforts and…
12 December 2019 By BioMedVic Comms On Thursday 5th December 2019 BioMedVic gathered a crowd in the beautiful Treetops room at the Melbourne Museum to celebrate twenty years of biomedical achievements. At this warm reception, BioMedVic counted with the participation…
13 December 2019 MTPConnect – the Australian Government’s Medical Technology, Biotechnology, and Pharmaceutical (MTP) Industry Growth Centre – and the Acting Minister for Health, the Hon Alan Tudge MP, today announced $14.8 million of funding for 17 early stage…
12 December 2019 Scientists from Australia and the US have discovered and identified the genetic cause of a previously unknown human autoinflammatory disease. The researchers determined that the autoinflammatory disease, which they termed CRIA (cleavage-resistant RIPK1-induced autoinflammatory) syndrome, is…
13 December 2019 Peter Mac scientists have found a way to target acute myeloid leukaemia (AML) at its source – a discovery that could yield a more effective treatment for this aggressive and often incurable blood cancer. Prof…
13 December 2019 PhD student Martha Blank from SVI’s Bone Cell Biology & Disease Unit was recently awarded the ATA Scientific Instruments Scientific Encouragement Award. My childhood ambition was…to become a veterinarian. My research interest is…bone mineralisation, because…
13 December 2019 Will Pye joined the SVI Foundation team in September, in a role created to give optimum support and acknowledgment to our existing major donors and to generate new supporters. “I am excited to bring 20…